Gastroenterology 132, 21312157
We understand that conditions like obesity and diabetes require comprehensive, long-term care, not a quick fix
These challenges were ultimately overcome through molecular modification, long-acting formulations, and a more sophisticated understanding of receptor pharmacology, including biased agonism and doseexposure relationships (Mller et al., 2019)
And for us as physicians, its frustrating
Because this effect was not statistically different from the neutral effects on nonfatal MI associated with the GLP-1RA class, we make no recommendation on the basis of this end point
Red flags that require immediate medical evaluation Seek medical help immediately if you experience any of the following while on a GLP-1 medication